BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $1.36 and last traded at $1.27, with a volume of 74859 shares. The stock had previously closed at $1.34.
BioRestorative Therapies Price Performance
The business’s 50 day simple moving average is $1.35 and its 200-day simple moving average is $1.66. The stock has a market capitalization of $2.02 billion, a P/E ratio of -1.15 and a beta of 102.36.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
Recommended Stories
- Five stocks we like better than BioRestorative Therapies
- Stock Splits, Do They Really Impact Investors?
- 3 Stocks Leading the U.S. Agriculture Comeback
- How to Invest in Insurance Companies: A Guide
- How to Use Put Debit Spreads to Profit From Falling Stocks
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
